scholarly article | Q13442814 |
P356 | DOI | 10.1086/587893 |
P8608 | Fatcat ID | release_yndw2vuusnd5nklzktqi6y67mi |
P698 | PubMed publication ID | 18433335 |
P5875 | ResearchGate publication ID | 5420237 |
P50 | author | Françoise Perdreau-Remington | Q115868118 |
Simon O'Hanlon | Q29998772 | ||
Mark Enright | Q41847851 | ||
Jonathan C Thomas | Q79411305 | ||
Henry F Chambers | Q89407615 | ||
Binh An Diep | Q115867976 | ||
P2093 | author name string | Peter Jensen | |
Brian S Schwartz | |||
Li Basuino | |||
Christopher J Graber | |||
Richard Jacobs | |||
Catherine Liu | |||
Shelley Gordon | |||
Michael Karr | |||
Gifford Leoung | |||
Helen Gunthorpe | |||
James S Rumack | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | San Francisco | Q62 |
epidemiology | Q133805 | ||
Staphylococcus aureus | Q188121 | ||
methicillin-resistant Staphylococcus aureus | Q595158 | ||
P304 | page(s) | 1637-1646 | |
P577 | publication date | 2008-06-01 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005 | |
P478 | volume | 46 |
Q35178848 | A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001-2010. |
Q38420470 | A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail. |
Q37868663 | A retrospective review of streptococcal infections in pediatric atopic dermatitis |
Q41042665 | Absence of the mecA Gene in Methicillin Resistant Staphylococcus aureus Isolated from Different Clinical Specimens in Shendi City, Sudan |
Q99548876 | Algae Polyphenolic Compounds and Modern Antibacterial Strategies: Current Achievements and Immediate Prospects |
Q35379738 | Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach |
Q33826253 | Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008 |
Q29616084 | Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America |
Q30393422 | Basis of Virulence in Community-Associated Methicillin-ResistantStaphylococcus aureus |
Q42220885 | Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study |
Q42284810 | Changing epidemiology of methicillin-resistant Staphylococcus aureus colonization in paediatric intensive-care units |
Q57716541 | Changing epidemiology of methicillin-resistant Staphylococcus aureus in Alberta, Canada: population-based surveillance, 2005–2008 |
Q34489712 | Changing epidemiology of methicillin-resistant Staphylococcus aureus in Iceland from 2000 to 2008: a challenge to current guidelines |
Q91915202 | Characteristics and risk factors of hospital acquired - Methicillin-resistant Staphylococcus aureus (HA-MRSA) infection of pediatric patients in a tertiary care hospital in Riyadh, Saudi Arabia |
Q34157657 | Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children |
Q46264770 | Clonality of Staphylococcus aureus colonization over time in attendees of a camp for children with chronic dermatoses |
Q35736907 | Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? |
Q38023627 | Community-associated methicillin-resistant Staphylococcus aureus and athletes |
Q33792021 | Community-associated methicillin-resistant Staphylococcus aureus case studies |
Q24614464 | Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic |
Q36438720 | Community-associated meticillin-resistant Staphylococcus aureus |
Q37465197 | Community-associated meticillin-resistant Staphylococcus aureus infections: epidemiology, recognition and management |
Q45979789 | Comparative Genomics of Community-Associated Methicillin-Resistant Staphylococcus aureus Shows the Emergence of Clone ST8-USA300 in Geneva, Switzerland. |
Q37225887 | Comparative Molecular Characteristics of Community-Associated and Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Isolates From Adult Patients in Northern Taiwan |
Q36853965 | Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus |
Q34802617 | Current status of Staphylococcus aureus infection in a central teaching hospital in Shanghai, China |
Q27015365 | Development of a vaccine against Staphylococcus aureus |
Q89522471 | Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies |
Q35807224 | Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California |
Q36256138 | Discriminatory Indices of Typing Methods for Epidemiologic Analysis of Contemporary Staphylococcus aureus Strains |
Q43977829 | Distribution of methicillin-resistant Staphylococcus aureus in a low-prevalence area |
Q34700948 | Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California |
Q37470451 | Diversity of methicillin-resistant Staphylococcus aureus strains isolated from residents of 26 nursing homes in Orange County, California |
Q47396324 | Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options). |
Q36882495 | Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. |
Q34531313 | Emergence of community-associated methicillin-resistant Staphylococcus aureus carriage in children in Cambodia |
Q38599573 | Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization |
Q34542185 | Epidemics of community-associated methicillin-resistant Staphylococcus aureus in the United States: a meta-analysis |
Q37387212 | Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals |
Q37392917 | Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. |
Q34343212 | Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus |
Q38587293 | Evolving Epidemiology of Staphylococcus aureus Bacteremia |
Q50221694 | Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells |
Q42110580 | Front-loaded linezolid regimens result in increased killing and suppression of the accessory gene regulator system of Staphylococcus aureus. |
Q36337074 | Global fluoroquinolone resistance epidemiology and implictions for clinical use. |
Q35214682 | High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania |
Q48226214 | In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus. |
Q37190797 | In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. |
Q28384260 | Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study |
Q35979644 | Internet queries and methicillin-resistant Staphylococcus aureus surveillance |
Q37800939 | Invasive community-associated MRSA infections: epidemiology and antimicrobial management |
Q33703737 | Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates |
Q28087717 | Livestock-Associated MRSA: The Impact on Humans |
Q36565462 | Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall |
Q40175113 | Mechanisms of pyocyanin toxicity and genetic determinants of resistance in Staphylococcus aureus |
Q37810406 | Methicillin-ResistantStaphylococcus aureus: A Community Health Threat |
Q37690736 | Methicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007. |
Q37410587 | Molecular and phenotypic characteristics of methicillin-resistant and vancomycin-intermediate staphylococcus aureus isolates from patients with septic arthritis |
Q34001847 | Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals. |
Q33594673 | Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis |
Q34056748 | Molecular pathogenesis of Staphylococcus aureus infection |
Q37374776 | Molecular surveillance and population structure analysis of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in high-risk wards |
Q36505512 | Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. |
Q27024628 | Neutrophils in innate host defense against Staphylococcus aureus infections |
Q37658260 | Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic |
Q33430160 | Pediatricians' perspectives on the impact of MRSA in primary care: a qualitative study |
Q36562825 | Polymorphisms in HLA Class II Genes Are Associated With Susceptibility to Staphylococcus aureus Infection in a White Population |
Q37156850 | Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers |
Q57815323 | Prevalence and risk factors of community-associated methicillin-resistant carriage in Asia-Pacific region from 2000 to 2016: a systematic review and meta-analysis |
Q26829702 | Progress toward a Staphylococcus aureus vaccine |
Q36915928 | Prolonged colonization with the methicillin-resistant Staphylococcus aureus strain USA300 among residents of extended care facilities. |
Q92276235 | Proteomics and Docking Study Targeting Penicillin-Binding Protein and Penicillin-Binding Protein2a of Methicillin-Resistant Staphylococcus aureus Strain SO-1977 Isolated from Sudan |
Q40120838 | Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting |
Q36916829 | Reduction of methicillin-resistant Staphylococcus aureus infection among veterans in Atlanta |
Q37328515 | Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. |
Q37998398 | Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example |
Q45968817 | Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. |
Q39901128 | Significantly larger numbers of methicillin-resistant Staphylococcus aureus bacteria are recovered from polymicrobial respiratory and wound sites by use of chromogenic primary media than by use of conventional culture |
Q34097990 | Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost. |
Q30998878 | Skin and soft-tissue infections in suburban primary care: epidemiology of methicillin-resistant Staphylococcus aureus and observations on abscess management |
Q34438470 | Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi |
Q91749993 | Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective study |
Q35689101 | Spontaneous staphylococcal cassette chromosome mec element excision in Staphylococcus aureus nasal carriers |
Q31057448 | Staphylococcal Panton-Valentine leukocidin induces pro-inflammatory cytokine production and nuclear factor-kappa B activation in neutrophils |
Q38151142 | Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage |
Q33604961 | Staphylococcus aureus - antimicrobial resistance and the immunocompromised child |
Q35193427 | Staphylococcus aureus infections in US veterans, Maryland, USA, 1999-2008 |
Q34478074 | Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. |
Q37203727 | The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300. |
Q30525482 | The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). |
Q54190309 | The mechanism of antibacterial activity of phlorofucofuroeckol-A against methicillin-resistant Staphylococcus aureus. |
Q37090265 | The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogens |
Q33523664 | To screen or not to screen for methicillin-resistant Staphylococcus aureus |
Q36023013 | Trends and characteristics of culture-confirmed Staphylococcus aureus infections in a large U.S. integrated health care organization |
Q44942892 | Trends in annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-infected and HIV-uninfected patients |
Q33961776 | Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States |
Q95355781 | Vancomycin Resistance in Staphylococcus aureus |
Q42153532 | Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates |
Q57614217 | Variability of SCCmec in the Zurich area |
Q30397807 | Wall teichoic acids mediate increased virulence in Staphylococcus aureus |
Q33854398 | Waves of resistance: Staphylococcus aureus in the antibiotic era. |
Q57921961 | What has molecular epidemiology ever done for wildlife disease research? Past contributions and future directions |
Search more.